Corvex (MOVE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
31 Aug, 2026Investment highlights
Positioned as a rare, public pure-play AI infrastructure company with significant growth potential in a rapidly expanding market segment.
Multiple value engines: scaling AI Factory MWs 5x, proprietary Token Factory for TAM growth, and differentiated security for sensitive AI workloads.
Experienced leadership and management team with proven track records in technology, infrastructure, and capital markets.
Attractive equity returns projected for near-term investments, supported by contracted data center expansions and a robust pipeline.
Market opportunity and differentiation
Exponential AI demand growth is expected to outpace supply, creating a favorable environment for infrastructure providers.
Limited public market access to AI infrastructure investments, with few rapidly scaling public AI companies.
Differentiation through proprietary security, cost-effective token-based intelligence, and vertical integration from site selection to delivery.
Addressable market expanding across AI infrastructure, inference services, and AI security software.
Growth strategy and execution
Three complementary growth vectors: AI Factory (GPU clusters), Token Factory (API-based AI model access), and Assured AI (runtime security software).
5x data center capacity growth under contract, with hundreds of MWs in the pipeline and options for further expansion.
Focus on long-term recurring revenue contracts, credit-quality customers, and high-margin software upsell opportunities.
Rapid deployment and operational excellence demonstrated by fast GPU cluster installations and performance improvements.
Latest events from Corvex
- AI cloud platform seeks $500M for growth, leveraging merger and improved 2025 financials.MOVE
Registration filing - Q2 2026 revenue was $3.8M, net loss $(12.8)M, and live compute ARR reached $22M.MOVE
Q2 2026 - AI cloud platform registers 53.4M shares for resale, with no new capital raised and high dilution risk.MOVE
Registration filing - All proposals, including board expansion and stock plans, were approved as the company pivots to AI.MOVE
AGM 2026 - Shareholders to approve director elections, share issuances, equity plans, and auditor after a major merger.MOVE
Proxy filing - Proxy seeks approval for merger-related equity, new plans, and board elections, with full board support.MOVE
Proxy filing - Q1 2026 revenue rose 148% to $510K, with pro forma revenue at $3.7M after the AI-focused merger.MOVE
Q1 2026 - Merger completed, AI focus established, healthcare sales paused, FY2025 net loss $18.3M on $0.4M revenue.MOVE
Q4 2025 - 2024 revenue grew to $1.0M, but ongoing losses and cash needs raise going concern risks.MOVE
Q4 2024